Since activation of either one of the TRAIL receptors has been previously shown to be sufficient for inducing apoptosis, we next investigated whether recombinant TRAIL was able to induce apoptosis in both highly NK- and low NK-sensitive melanoma cell lines. The gene discussed is TNFSF10; the disease is melanoma.